On Demand:Cardiovascular Pharmacotherapy Update
June 25-26 2025 Lake Placid NY
“Dr. Saseem is awesome. His knowledge of lipid lowering drug clinical trials is impressive and inspirational. You can always tell a good conference by the level of engagement between the class and speaker. The questions and discussion are the best I’ve ever experienced. There’s not a question he won’t take the time to answer.
The course was very well organized. The topics and information was relevant and presented in a way that was easy to understand. The speaker was engaging, knowledgeable, and concise.
This session on lipids was exactly what I needed!!! Thank you - very informative!
I also really appreciate the discussion about the development of new drugs in trials and when they are supposed to be approved or not. Not many speakers give that information and it’s so good to know!!
Appreciated the in-depth overview on cholesterol, statins and management.
Incredible day of content, thank you so much! Dr. Sanseen is engaging and energetic. His knowledge and the way he delivers the information is exceptional!
”
-
1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension
2. Review lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease
3. Summarize how future cardiovascular risk is estimated in primary prevention patients using the Pooled Cohort Equations and PREVENT calculator
4. Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement
5. Describe emerging pharmacotherapies for the treatment of hypertension
6. List guideline recommendations supporting the use of antiplatelet therapy for primary prevention patients
7. Examine the evidence-based CV risk reduction benefits of medications used to treat overweight and obese patients
8. Create treatment plans that reduce the risk of cardiovascular disease
-
1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypercholesterolemia, chronic coronary disease, and peripheral arterial disease
2. Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia
3. Interpret recommendations from the ACC Expert Consensus Decision Pathway for non-statins and treatment of hypertriglyceridemia
4. Define the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia
5. Describe the evidence and guideline recommendations supporting the use of antiplatelet and antithrombotic therapy for secondary prevention patients
6. List evidence-based drug therapy recommendations for the management of patients with chronic coronary disease and peripheral arterial disease
7. Evaluate the role of colchicine in the prevention of CV events
8. Create treatment plans that reduce the risk of cardiovascular disease
-
1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, and atrial fibrillation
2. Describe the pillars of therapy for heart failure
3. Examine results from cardiovascular outcome trials evaluating the use of angiotensin–neprilysin inhibition in heart failure with reduce ejection fraction
4. Examine results from cardiovascular outcome trials evaluating the use of SGLT2 inhibitors in heart failure
5. Discuss pharmacotherapy used for reducing the risk of stroke and rate and rhythm control in atrial fibrillation.
6. Recall strategies to promote health equity in cardiovascular disease management.
7. Create treatment plans that reduce the risk of cardiovascular disease
About This Course
Recorded live in Lake Placid in June 25-26 2025.
Provides 15 Hours of ACPE Home Study credit.
Valid through June 26, 2028
Price $250
Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
Accreditation Information - ACPE On Demand
PHARMACISTS:
University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for all pharmacists. On-demand courses provide HOME STUDY credit only.
University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Pharmacy.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
NURSE PRACTITIONERS
American Nurses Credentialing Center (ANCC) : This course fulfills the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Continuing Education Hours or certification renewal as well as other Nurse Practitioner credentialing organizations that accept ACPE credit. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure.
American Association of Nurse Practitioners (AANP) This program offers Category 2 credit only. AANP only accepts on demand courses approved for AMA PRA Category 1 Credit™.
NURSES
University Learning Systems is approved by theCalifornia Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
CE Broker is approved by these Boards of Nursing: Arkansas, Florida, District of Columbia, Georgia, Kentucky, New Mexico, North Dakota, South Carolina, West Virginia.The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.
PHYSICIANS/ PHYSICIAN ASSISTANTS:
This CME program offers Category 2 credit only.
American Academy of Physician Assistants (AAPA) This CME program offers Category 2 credit.
OTHER HEALTH PROFESSIONALS: Please contact your respective board regarding approval.